IV Disinfecting Caps Market Size

  • Report ID: 4101
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

IV Disinfecting Caps Market Size

IV Disinfecting Caps Market size was valued at USD 387.9 Billion in 2023 and is likely to cross USD 1.37 Trillion by the end of 2036, registering more than 10.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of IV disinfecting caps is estimated at USD 423.51 Billion. The growth of the market can be attributed to the increasing incidence of cancer across the globe. The demand for IV disinfectant caps increases as a result of growing cases of cancer. For instance, to avoid infections in cancer patients, the use of IV disinfectant caps can be a crucial strategy. Infection control is an essential component of these patients' care as it may make them more vulnerable to infections. Further, the growing popularity of infection prevention in healthcare settings across the globe is also expected to add to the market growth. According to estimates, there would be over 16 million cancer-related deaths and more than 29 million new instances of cancer globally by 2040.

In addition to these, factors that are believed to fuel the market growth of IV disinfecting caps include the rise in technological advancements in IV disinfectant caps. For instance, certain IV disinfectant caps now have wireless monitoring and tracking features, which enable healthcare professionals to trace IV line usage in real-time and check adherence to disinfection guidelines.


IV Disinfecting Caps Market share
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4101
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of IV disinfecting caps is estimated at USD 423.51 Billion.

The IV disinfecting caps market size was valued at USD 387.9 Billion in 2023 and is likely to cross USD 1.37 Trillion by the end of 2036, registering more than 10.2% CAGR during the forecast period i.e., between 2024-2036. Growing health awareness and the rising geriatric population are the major factors driving the market growth.

North America is expected to account for majority industry share by 2036, attributed to growing number of surgeries.

Human Metabolome Technologies America Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Biocrates life sciences AG, Agilent Technologies, Inc., Merit Medical Systems, B. Braun Melsungen AG, ICU Medical, Inc., Becton, Dickinson and Company, 3M Company
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample